RNAC icon

Cartesian Therapeutics

79 hedge funds and large institutions have $144M invested in Cartesian Therapeutics in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

17% less capital invested

Capital invested by funds: $174M → $144M (-$30.4M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$361K
Puts
$97K
Net Calls
Net Calls Change

Top Buyers

1 +$3.97M
2 +$2.54M
3 +$2.42M
4
Northern Trust
Northern Trust
Illinois
+$1.62M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.52M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$21M
2
$11.6M
3
$11.2M
4
$10.9M
5
$9.49M
6
$8.14M
7
$7.16M
8
$6.88M
9
$6.24M
10
$5.86M
11
$5.19M
12
$5.13M
13
$3.75M
14
$2.94M
15
$2.74M
16
$2.54M
17
$2.35M
18
$2.29M
19
$2M
20
$1.95M
21
$1.77M
22
$1.28M
23
$1.23M
24
$992K
25
$743K